Goncharova I A, Zarubin A A, Babushkina N P, Koroleva I A, Nazarenko M S
Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
Vavilovskii Zhurnal Genet Selektsii. 2023 Mar;27(1):72-82. doi: 10.18699/VJGB-23-10.
In this study we compared methylation levels of 27,578 CpG sites between paired samples of the tumor and surrounding liver tissues with various degrees of damage (fibrosis, cirrhosis) in HCV-induced hepatocellular carcinoma (HCC) patients, as well as between tumor and normal tissue in non-viral HCC patients, using GSE73003 and GSE37988 data from GEODataSets (https://www.ncbi.nlm.nih.gov/). A significantly lower number of differentially methylated sites (DMS) were found between HCC of non-viral etiology and normal liver tissue, as well as between HCC and fibrosis (32 and 40), than between HCC and cirrhosis (2450 and 2304, respectively, according to GSE73003 and GSE37988 datasets). As the pathological changes in the tissue surrounding the tumor progress, the ratio of hyper-/hypomethylated DMSs in the tumor decreases. Thus, in tumor tissues compared with normal/fibrosis/cirrhosis of the liver, 75/62.5/47.7 % (GSE73003) and 16 % (GSE37988) of CpG sites are hypermethylated, respectively. Persistent hypermethylation of the ZNF154 and ZNF540 genes, as well as CCL20 hypomethylation, were registered in tumor tissue in relation to both liver fibrosis and liver cirrhosis. Protein products of the EDG4, CCL20, GPR109A, and GRM8 genes, whose CpG sites are characterized by changes in DNA methylation level in tumor tissue in the setting of cirrhosis and fibrosis, belong to "Signaling by G-protein-coupled receptors (GPCRs)" category. However, changes in the methylation level of the "driver" genes for oncopathology (АРС, CDKN2B, GSTP1, ELF4, TERT, WT1) are registered in tumor tissue in the setting of liver cirrhosis but not fibrosis. Among the genes hypermethylated in tumor tissue in the setting of liver cirrhosis, the most represented biological pathways are developmental processes, cell-cell signaling, transcription regulation, Wnt-protein binding. Genes hypomethylated in liver tumor tissue in the setting of liver cirrhosis are related to olfactory signal transduction, neuroactive ligand-receptor interaction, keratinization, immune response, inhibition of serine proteases, and zinc metabolism. The genes hypermethylated in the tumor are located at the 7p15.2 locus in the HOXA cluster region, and the hypomethylated CpG sites occupy extended regions of the genome in the gene clusters of olfactory receptors (11p15.4), keratin and keratin-associated proteins (12q13.13, 17q21.2, and 21q22.11), epidermal differentiation complex (1q21.3), and immune system function loci 9p21.3 (IFNA, IFNB1, IFNW1 cluster) and 19q13.41-19q13.42 (KLK, SIGLEC, LILR, KIR clusters). Among the genes of fibrogenesis or DNA repair, cg14143055 (ADAMDEC1) is located in the binding region of the HOX gene family transcription factors (TFs), while cg05921699 (CD79A), cg06196379 (TREM1) and cg10990993 (MLH1) are located in the binding region of the ZNF protein family transcription factor (TF). Thus, the DNA methylation profile in the liver in HCV-induced HCC is unique and differs depending on the degree of surrounding tissue lesion - liver fibrosis or liver cirrhosis.
在本研究中,我们利用来自GEODataSets(https://www.ncbi.nlm.nih.gov/)的GSE73003和GSE37988数据,比较了丙型肝炎病毒(HCV)诱导的肝细胞癌(HCC)患者中肿瘤与周围肝脏组织(有不同程度损伤,即纤维化、肝硬化)的配对样本之间27,578个CpG位点的甲基化水平,以及非病毒性HCC患者肿瘤与正常组织之间的甲基化水平。与非病毒性病因的HCC和正常肝组织之间以及HCC和纤维化之间相比(分别为32个和40个差异甲基化位点),HCC和肝硬化之间发现的差异甲基化位点(DMS)数量显著更低(根据GSE73003和GSE37988数据集分别为2450个和2304个)。随着肿瘤周围组织病理变化的进展,肿瘤中高甲基化/低甲基化DMS的比例降低。因此,与肝脏的正常/纤维化/肝硬化相比,肿瘤组织中分别有75/62.5/47.7%(GSE73003)和16%(GSE3- 7988)的CpG位点发生高甲基化。在肿瘤组织中,相对于肝纤维化和肝硬化,ZNF154和ZNF540基因持续高甲基化,以及CCL20低甲基化。EDG4、CCL20、GPR109A和GRM8基因的蛋白质产物,其CpG位点在肝硬化和纤维化背景下的肿瘤组织中表现出DNA甲基化水平变化,属于“G蛋白偶联受体(GPCRs)信号传导”类别。然而,肿瘤病理学的“驱动”基因(АРС、CDKN2B、GSTP1、ELF4、TERT、WT1)的甲基化水平变化在肝硬化而非纤维化背景下的肿瘤组织中被检测到。在肝硬化背景下肿瘤组织中高甲基化的基因中,最具代表性的生物学途径是发育过程、细胞间信号传导、转录调控、Wnt蛋白结合。在肝硬化背景下肝脏肿瘤组织中低甲基化的基因与嗅觉信号转导、神经活性配体 - 受体相互作用、角化、免疫反应、丝氨酸蛋白酶抑制和锌代谢有关。肿瘤中高甲基化的基因位于HOXA簇区域的7p15.2位点,而低甲基化的CpG位点占据嗅觉受体基因簇(11p15.4)、角蛋白和角蛋白相关蛋白(12q13.13、17q21.2和21q22.11)、表皮分化复合体(1q21.3)以及免疫系统功能位点9p21.3(IFNA、IFNB1、IFNW1簇)和19q13.41 - 19q13.42(KLK、SIGLEC、LILR、KIR簇)中的基因组扩展区域。在纤维生成或DNA修复基因中,cg14143055(ADAMDEC1)位于HOX基因家族转录因子(TFs)的结合区域,而cg05921699(CD79A)、cg06196379(TREM1)和cg10990993(MLH1)位于ZNF蛋白家族转录因子(TF)的结合区域。因此,HCV诱导的HCC中肝脏的DNA甲基化谱是独特的,并且根据周围组织病变程度(肝纤维化或肝硬化)而有所不同。